Low levels of leptin and very low levels of adipokines may be associated with metabolic complications, such as type 2 diabetes mellitus, hypertriglyceridemia, metabolic dysfunction-associated steatotic liver disease (MASCD), and severe insulin resistance [131]. Here, LEP is linked to hypertriglyceridemia.